Severe acute respiratory syndrome coronavirus 2 spike antibody level decline is more pronounced after the second vaccination, but response to the third vaccination is similar in people with type 1 and type 2 diabetes compared with healthy controls: the prospective COVAC-DM cohort study

File(s)

Diabetes Obesity Metabolism - 2022 - Sourij - Severe acute respiratory syndrome coronavirus 2 spike antibody level decline.pdf (539.49 KB)

Published version

Show more

Author(s)

Sourij, Caren

Aziz, Faisal

Kojzar, Harald

Obermayer, Anna M

Sternad, Christoph

more

Type

Journal Article

Date Issued

2023-01

Date Acceptance

2022-08-29

Citation

Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 2023, 25 (1), pp.314-318

URI

http://hdl.handle.net/10044/1/116680

URL

https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14855

DOI

https://www.dx.doi.org/10.1111/dom.14855

ISSN

1462-8902

Publisher

Wiley

Start Page

314

End Page

318

Journal / Book Title

Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics

Volume

25

Issue

1

Copyright Statement

© 2022 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.


This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

License URL

https://creativecommons.org/licenses/by/4.0/

Identifier

https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000853729400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb

Subjects

COVID-19

Endocrinology & Metabolism

Life Sciences & Biomedicine

Science & Technology

type 1 diabetes

type 2 diabetes

vaccination

Publication Status

Published

Date Publish Online

2022-09-04